Recro Pharma: Tumbles as Q4 revenue falls, net loss widens

Societal CDMO

26/02/2021 14:52

** Shares of contract development and manufacturing co
 REPH.O  decline about 26.7% to $3.60
    ** REPH's Q4 revenue drops 43.8% to $9.9 mln compared to a
year earlier  urn:newsml:reuters.com:*:nGNX9pYVsR
    ** REPH's net loss, including non-cash charges, widens to
$11.7 mln from $4.7 mln
    ** Co says full-year revenue was hurt by competition and
sharply reduced prescriptions due to the COVID-19 pandemic
    ** Says it expects revenue for Q1 to increase by about 65%
-70% from Q4 
    ** REPH had surged 72.3%, as of its last close
    

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))